Member

Jun Ishihara(Associate Professor)

Dr. Jun Ishihara is an Associate Professor in the Department of Bioengineering at Imperial College London. The Ishihara laboratory works in the field of protein engineering, with research foci in cancer immunotherapy, autoimmunity, and regenerative medicine.

Dr. Ishihara received his PhD in stem cell biology from the University of Tokyo. He then conducted postdoctoral training in the laboratory of Jeffrey Hubbell, first at the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland from 2014 to 2016 and then at the University of Chicago from 2016 to 2020, when the laboratory relocated to the Pritzker School of Molecular Engineering. 

Dr. Ishihara has developed novel technologies in the field of immunoengineering to improve current therapies and discover new drugs. He has developed novel approaches to cancer immunotherapy that achieve localised immune activation by targeting the tumour microenvironment. These methods make cancer immunotherapy safe and effective. Dr. Ishihara has also developed treatments for autoimmune diseases, including rheumatoid arthritis and multiple sclerosis. In the field of regenerative medicine, he has developed novel approaches to deliver growth factors to the wound site efficiently, promoting wound healing.

Dr. Ishihara has co-authored 31 scientific papers and 16 patents, with publications in Nature Biomedical Engineering, Science Translational Medicine, Science Advances, Blood and Nature Communications. He is also a co-founder of Arrow Immune Inc., focusing on the clinical translation of cancer immunotherapy techniques. Additionally, he is a co-founder of HeioThera Inc., which focuses on the clinical translation of anti-inflammatory therapeutics, and ScienceLounge LLC, which operates a science bar in Tokyo for scientific outreach activities.

Publication List

2021

Journal

2020

Journal

2019

Journal

2018

Journal

2017

Journal

2015

Journal

2014

Journal

2012

Journal